Lundblad, M <br/><br/>
Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.  [electronic resource] 

 -  Experimental neurology  Jul 2005 
 - 66-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study 
<br/><br/><label>ISSN: </label>0014-4886 
<br/><br/><label>Standard No.: </label>10.1016/j.expneurol.2005.02.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine A2 Receptor Agonists<br/>Adrenergic Agents--adverse effects<br/>Amantadine--pharmacology<br/>Animals<br/>Antiparkinson Agents--pharmacology<br/>Basal Ganglia--drug effects<br/>Buspirone--pharmacology<br/>Disease Models, Animal<br/>Disease Progression<br/>Dopamine Agonists--pharmacology<br/>Drug Administration Schedule<br/>Dyskinesia, Drug-Induced--drug therapy<br/>Indoles--pharmacology<br/>Levodopa--administration & dosage<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Oxidopamine<br/>Parkinsonian Disorders--chemically induced<br/>Purines--pharmacology<br/>Receptor, Adenosine A2A--metabolism<br/>Receptors, Dopamine D2--agonists<br/>Reproducibility of Results<br/>Riluzole--pharmacology<br/>Treatment Outcome